Cargando…

BMI is associated with FEV(1) decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials

BACKGROUND: There is considerable heterogeneity in the rate of lung function decline in chronic obstructive pulmonary disease (COPD), the determinants of which are largely unknown. Observational studies in COPD indicate that low body mass index (BMI) is associated with worse outcomes, and overweight...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yilan, Milne, Stephen, Jaw, Jen Erh, Yang, Chen Xi, Xu, Feng, Li, Xuan, Obeidat, Ma’en, Sin, Don D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819522/ https://www.ncbi.nlm.nih.gov/pubmed/31665000 http://dx.doi.org/10.1186/s12931-019-1209-5

Ejemplares similares

Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review
por: Whittaker, Hannah R., et al.
Publicado: (2019)

The genetics of smoking in individuals with chronic obstructive pulmonary disease
por: Obeidat, Ma’en, et al.
Publicado: (2018)

Obstructive sleep apnoea accelerates FEV(1) decline in asthmatic patients
por: Wang, Tsai-Yu, et al.
Publicado: (2017)

Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis
por: Bouzek, Drake C., et al.
Publicado: (2022)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Rate of Decline of FEV(1) as a Biomarker of Survival?
por: Papi, Alberto, et al.
Publicado: (2021)

Rapid FEV(1)/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population
por: Choi, Kwang Yong, et al.
Publicado: (2022)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis
por: Boëlle, Pierre-Yves, et al.
Publicado: (2012)

Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV(1) decline
por: de Aquino, Carolina Silva Barboza, et al.
Publicado: (2022)

Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease
por: Li, Xuan, et al.
Publicado: (2017)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients
por: Frye, Björn Christian, et al.
Publicado: (2021)

Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Jen, Rachel, et al.
Publicado: (2012)

Systematic review with meta-analysis of the epidemiological evidence relating FEV(1) decline to lung cancer risk
por: Fry, John S, et al.
Publicado: (2012)

Network-based analysis reveals novel gene signatures in peripheral blood of patients with chronic obstructive pulmonary disease
por: Obeidat, Ma’en, et al.
Publicado: (2017)

Systematic review of the evidence relating FEV(1 )decline to giving up smoking
por: Lee, Peter N, et al.
Publicado: (2010)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

FEV(6) as screening tool in diagnosis of obstructive airway disease
por: Aggarwal, Sourabh
Publicado: (2010)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Annual change in FEV(1) in elderly 10-year survivors with established chronic obstructive pulmonary disease
por: Suzuki, Masaru, et al.
Publicado: (2019)

Association between annual change in FEV(1) and comorbidities or impulse oscillometry in chronic obstructive pulmonary disease
por: Sugawara, Hiroyuki, et al.
Publicado: (2022)

Variability of FEV(1) and Criterion for Acute Pulmonary Exacerbation
por: Jenkins, Bradlee A., et al.
Publicado: (2014)

Decline in FEV(1) and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
por: Hiller, Adriana-Maria, et al.
Publicado: (2019)

Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART
por: Samperiz, Gloria, et al.
Publicado: (2019)

FEV(6) as screening tool in spirometric diagnosis of obstructive airway disease
por: Malolan, P. Adithya, et al.
Publicado: (2010)

Widespread Sexual Dimorphism in the Transcriptome of Human Airway Epithelium in Response to Smoking
por: Yang, Chen Xi, et al.
Publicado: (2019)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Genome organization and molecular characterization of the three Formica exsecta viruses—FeV1, FeV2 and FeV4
por: Dhaygude, Kishor, et al.
Publicado: (2019)

Understanding the natural progression in %FEV(1) decline in patients with cystic fibrosis: a longitudinal study
por: Taylor-Robinson, David, et al.
Publicado: (2012)

Polymorphisms of ATF6B Are Potentially Associated With FEV1 Decline by Aspirin Provocation in Asthmatics
por: Park, Tae-Joon, et al.
Publicado: (2014)

Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study
por: Talini, Donatella, et al.
Publicado: (2015)

FEV(1) decline in relation to blood eosinophils and neutrophils in a population-based asthma cohort
por: Backman, Helena, et al.
Publicado: (2020)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Diagnostic accuracy of pre-bronchodilator FEV(1)/FEV(6) from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study
por: van den Bemt, Lisette, et al.
Publicado: (2014)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Kakavas, Sotirios, et al.
Publicado: (2021)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Retrospective Analysis of the Relationship between Decline in FEV(1) and Abdominal Circumference in Male Smokers: the Takahata Study
por: Sato, Masamichi, et al.
Publicado: (2012)

Predictors of accelerated FEV(1) decline in adults with airflow limitation—Findings from the Health2006 cohort
por: Baarnes, Camilla Boslev, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_39e3qgv6253t2rriku4vncpmqk